ModivCare Inc. (MODV)
USD 0.99
(-1.04%)
USD 0.99
(-1.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.75 Million USD | -1.76% |
| 2022 | 157.49 Million USD | 7.31% |
| 2021 | 146.76 Million USD | -7.23% |
| 2020 | 148.22 Million USD | 1203.14% |
| 2019 | 12.14 Million USD | -79.76% |
| 2018 | 40.07 Million USD | -24.96% |
| 2017 | 51.1 Million USD | 19.18% |
| 2016 | 67.05 Million USD | -5.99% |
| 2015 | 15.75 Million USD | -9.42% |
| 2014 | 71.86 Million USD | 45.45% |
| 2013 | 52.98 Million USD | 29.33% |
| 2012 | 41.73 Million USD | -17.11% |
| 2011 | 50.74 Million USD | -28.07% |
| 2010 | 70.21 Million USD | 4.88% |
| 2009 | 66.94 Million USD | 95.09% |
| 2008 | -135.61 Million USD | 10.72% |
| 2007 | 30.99 Million USD | 62.59% |
| 2006 | 19.06 Million USD | 1.87% |
| 2005 | 18.71 Million USD | 43.88% |
| 2004 | 13.07 Million USD | 46.26% |
| 2003 | 7.84 Million USD | 22.86% |
| 2002 | 3.66 Million USD | -94.33% |
| 2001 | 127.53 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 26.65 Million USD | -36.94% |
| 2024 Q2 | 36.1 Million USD | -367.0% |
| 2023 Q3 | 38.12 Million USD | 14.66% |
| 2023 Q4 | 39.64 Million USD | 4.01% |
| 2023 FY | - USD | -1.76% |
| 2023 Q1 | 33.79 Million USD | 3.48% |
| 2023 Q2 | 33.24 Million USD | -1.61% |
| 2022 Q3 | 38.11 Million USD | -20.43% |
| 2022 Q4 | 32.65 Million USD | -14.33% |
| 2022 FY | - USD | 7.31% |
| 2022 Q2 | 47.9 Million USD | 23.4% |
| 2022 Q1 | 38.82 Million USD | -4.37% |
| 2021 Q3 | 18.98 Million USD | -52.12% |
| 2021 Q1 | 45.55 Million USD | 71.4% |
| 2021 FY | - USD | -7.23% |
| 2021 Q2 | 39.65 Million USD | -12.96% |
| 2021 Q4 | 40.59 Million USD | 113.82% |
| 2020 FY | - USD | 1203.14% |
| 2020 Q1 | 11.28 Million USD | 193.62% |
| 2020 Q2 | 59.37 Million USD | 426.15% |
| 2020 Q3 | 60.96 Million USD | 2.67% |
| 2020 Q4 | 26.58 Million USD | -56.4% |
| 2019 Q3 | 18.01 Million USD | 12438.36% |
| 2019 FY | - USD | -79.76% |
| 2019 Q1 | 6.32 Million USD | -59.08% |
| 2019 Q2 | -146 Thousand USD | -102.31% |
| 2019 Q4 | -12.05 Million USD | -166.91% |
| 2018 Q2 | 7.29 Million USD | -48.16% |
| 2018 Q4 | 15.45 Million USD | 37.03% |
| 2018 FY | - USD | -24.96% |
| 2018 Q1 | 14.07 Million USD | -66.56% |
| 2018 Q3 | 11.28 Million USD | 54.58% |
| 2017 Q2 | 14.42 Million USD | 31.21% |
| 2017 FY | - USD | 19.18% |
| 2017 Q4 | 42.09 Million USD | 239.62% |
| 2017 Q3 | 12.39 Million USD | -14.09% |
| 2017 Q1 | 10.99 Million USD | 62.58% |
| 2016 FY | - USD | -5.99% |
| 2016 Q4 | 6.76 Million USD | -66.69% |
| 2016 Q3 | 20.3 Million USD | -24.09% |
| 2016 Q2 | 26.75 Million USD | 10.2% |
| 2016 Q1 | 24.27 Million USD | 401.27% |
| 2015 Q3 | 17 Million USD | -49.73% |
| 2015 Q2 | 33.81 Million USD | -2.71% |
| 2015 Q1 | 34.76 Million USD | 0.69% |
| 2015 FY | - USD | -9.42% |
| 2015 Q4 | -8.05 Million USD | -147.39% |
| 2014 Q1 | 15.8 Million USD | 60.78% |
| 2014 Q2 | 18.6 Million USD | 17.7% |
| 2014 Q3 | 9.87 Million USD | -46.95% |
| 2014 Q4 | 34.52 Million USD | 249.72% |
| 2014 FY | - USD | 45.45% |
| 2013 Q3 | 11.74 Million USD | -25.26% |
| 2013 Q2 | 15.71 Million USD | -6.79% |
| 2013 FY | - USD | 29.33% |
| 2013 Q4 | 9.83 Million USD | -16.26% |
| 2013 Q1 | 16.85 Million USD | 39.9% |
| 2012 Q3 | 9.02 Million USD | 12.52% |
| 2012 Q4 | 12.04 Million USD | 33.48% |
| 2012 FY | - USD | -17.11% |
| 2012 Q1 | 10.26 Million USD | -4.77% |
| 2012 Q2 | 8.02 Million USD | -21.82% |
| 2011 Q3 | 9.39 Million USD | -29.44% |
| 2011 Q1 | 17.01 Million USD | 17.26% |
| 2011 Q2 | 13.31 Million USD | -21.78% |
| 2011 Q4 | 10.77 Million USD | 14.69% |
| 2011 FY | - USD | -28.07% |
| 2010 Q4 | 14.51 Million USD | 16.91% |
| 2010 Q2 | 20.17 Million USD | -12.72% |
| 2010 Q3 | 12.41 Million USD | -38.45% |
| 2010 Q1 | 23.11 Million USD | 27.58% |
| 2010 FY | - USD | 4.88% |
| 2009 FY | - USD | 95.09% |
| 2009 Q1 | 18.24 Million USD | 2699.12% |
| 2009 Q4 | 18.11 Million USD | 34.64% |
| 2009 Q3 | 13.45 Million USD | -21.47% |
| 2009 Q2 | 17.13 Million USD | -6.08% |
| 2008 FY | - USD | 10.72% |
| 2008 Q4 | 651.68 Thousand USD | -90.62% |
| 2008 Q3 | 6.94 Million USD | -49.91% |
| 2008 Q2 | 13.87 Million USD | -6.79% |
| 2008 Q1 | 14.88 Million USD | 37.11% |
| 2007 Q1 | 6.38 Million USD | 208.31% |
| 2007 Q2 | 7.1 Million USD | 11.32% |
| 2007 FY | - USD | 62.59% |
| 2007 Q3 | 6.65 Million USD | -6.39% |
| 2007 Q4 | 10.85 Million USD | 63.27% |
| 2006 Q2 | 6.23 Million USD | 12.81% |
| 2006 Q1 | 5.52 Million USD | 10.33% |
| 2006 Q4 | 2.06 Million USD | -60.43% |
| 2006 FY | - USD | 1.87% |
| 2006 Q3 | 5.23 Million USD | -16.11% |
| 2005 Q1 | 3.92 Million USD | -2.82% |
| 2005 Q2 | 4.52 Million USD | 15.1% |
| 2005 Q3 | 1.21 Million USD | -73.12% |
| 2005 Q4 | 5 Million USD | 312.01% |
| 2005 FY | - USD | 43.88% |
| 2004 Q2 | 2.76 Million USD | 27.84% |
| 2004 FY | - USD | 46.26% |
| 2004 Q1 | 2.16 Million USD | -4.96% |
| 2004 Q4 | 4.04 Million USD | 0.25% |
| 2004 Q3 | 4.03 Million USD | 45.88% |
| 2003 Q4 | 2.27 Million USD | -22.48% |
| 2003 FY | - USD | 22.86% |
| 2003 Q3 | 1.89 Million USD | 51.7% |
| 2003 Q2 | 1.93 Million USD | -79.66% |
| 2003 Q1 | 9.51 Million USD | 0.0% |
| 2002 FY | - USD | -94.33% |
| 2001 Q3 | 18.87 Million USD | -52.29% |
| 2001 Q4 | 3.68 Million USD | -80.49% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | 39.56 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 114.145% |
| Addus HomeCare Corporation | 106.55 Million USD | 125.104% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 194.483% |
| Amedisys, Inc. | 216.91 Million USD | 112.332% |
| American Oncology Network, Inc. | -39.35 Million USD | 32.022% |
| Astrana Health, Inc. | 123.68 Million USD | 121.627% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 160.318% |
| IMAC Holdings, Inc. | -5.94 Million USD | -349.822% |
| biote Corp. | 9.23 Million USD | 389.69% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -156.785% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 120.683% |
| COMPASS Pathways plc | -123.8 Million USD | 78.393% |
| DocGo Inc. | 32.72 Million USD | 181.741% |
| The Ensign Group, Inc. | 353.23 Million USD | 107.573% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 135.566% |
| InnovAge Holding Corp. | 1.15 Million USD | 2418.024% |
| Assure Holdings Corp. | -19.82 Million USD | -34.937% |
| The Joint Corp. | 9.14 Million USD | 392.615% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 74.506% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -71.974% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 7060.617% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -357.343% |
| Option Care Health, Inc. | 376.79 Million USD | 107.099% |
| P3 Health Partners Inc. | -81.07 Million USD | 67.004% |
| P3 Health Partners Inc. | -81.07 Million USD | 67.004% |
| The Pennant Group, Inc. | 30.36 Million USD | 188.083% |
| Surgery Partners, Inc. | 446.1 Million USD | 105.996% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -843.268% |
| Talkspace, Inc. | -22.01 Million USD | -21.519% |
| Talkspace, Inc. | -22.01 Million USD | -21.519% |
| The Oncology Institute, Inc. | -70.45 Million USD | 62.032% |
| The Oncology Institute, Inc. | -70.45 Million USD | 62.032% |